Diasome Pharmaceuticals, Inc.

New Filing
CIK: 0001411617·Biotechnology·DELAWARE·Filed: Dec 23, 2020
Total Offering

$5,000,000

Amount Sold

$1,500,000

Investors

6

First Sale

Sep 21, 2020

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Robert Geho
Related Person
W. Blair Geho
Related Person
THOMAS MCDONALD
Related Person
Frank McCaney
Related Person
Marc Penn
Related Person

Company

Diasome Pharmaceuticals, Inc.

10000 CEDAR AVENUE

CLEVELAND, OH, 44106

216-444-7110

SEC Filing

0001231919-20-000082

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Diasome Pharmaceuticals, Inc. Form D Filing — $5,000,000 | FilingFlow